文献速递疼痛医学神经外科与老年麻醉

KDM4A通过调控BDNF促进大鼠臂丛撕脱后神经病理性疼痛及小胶质细胞M1极化

KDM4A facilitates neuropathic pain and microglial M1 polarization by regulating BDNF in a rat model of brachial plexus avulsion.
PubMed 文献 · Reg Anesth Pain Med · 2026-02-05

该研究在大鼠臂丛撕脱(BPA)模型中探究KDM4A调控神经病理性疼痛的机制。BPA组脊髓同侧背角KDM4A与BDNF表达显著上调,敲低KDM4A可降低BDNF表达、减轻小胶质细胞增生及疼痛行为,过表达则相反。KDM4A通过调控BDNF启动子区组蛋白H3K9与H3K36甲基化来调节BDNF表达。

要点

  • BPA大鼠脊髓同侧背角KDM4A与BDNF表达显著上调。
  • 敲低KDM4A可减轻小胶质细胞增生与神经病理性疼痛行为。
  • KDM4A通过组蛋白H3K9与H3K36甲基化调控BDNF启动子。

核心结论

  • BPA大鼠脊髓中KDM4A上调增加BDNF表达,促进小胶质细胞增生、神经炎症及神经病理性疼痛。

研究设计与样本

  • 在成年大鼠中建立BPA手术疼痛模型,采用Western blot、ELISA、RT-PCR、免疫荧光、免疫共沉淀及染色质免疫沉淀PCR等方法。
  • 通过药理学与遗传学方法调控KDM4A表达,比较BPA组与假手术组。

主要发现

  • BPA组脊髓同侧背角KDM4A与BDNF水平较假手术组显著上调。
  • 敲低KDM4A降低BDNF表达、减轻小胶质细胞增生并减少神经病理性疼痛样行为。
  • 过表达KDM4A增加BDNF表达、加重小胶质细胞增生并加剧神经病理性疼痛。
  • BDNF抑制剂与激活剂同样调控脊髓小胶质细胞活化及神经病理性疼痛。
  • KDM4A通过调控BDNF启动子区组蛋白H3K9与H3K36甲基化来调节BDNF表达。

临床怎么用

  • KDM4A-BDNF轴可能为BPA相关神经病理性疼痛提供潜在干预靶点,但尚需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many patients with brachial plexus avulsion (BPA) suffer from neuropathic pain, but the mechanism remains elusive. Modifications of histones, the proteins responsible for organizing DNA, may play an important role in neuropathic pain. Lysine demethylase 4A (KDM4A), an essential component of histone demethylase, can modify the function of chromatin and thus regulate the vital gene expressions. However, the mechanism by which KDM4A regulates neuropathic pain following BPA remains unclear. METHODS: The pain model was developed in adult rats that received BPA surgery. Western blot, ELISA, and reverse transcription-PCR were used to examine the protein and mRNA levels of targeted genes. Immunofluorescence studies were conducted to analyze their cellular distribution in the spinal cord. Pharmacological and genetic methods were used to modulate the expression of KDM4A. Co-immunoprecipitation and chromatin immunoprecipitation PCR were used to assess the binding potential between KDM4A and the promoter of brain-derived neurotrophic factor (BDNF). RESULTS: KDM4A and BDNF levels were significantly upregulated in the ipsilateral spinal cord dorsal horn in the BPA group compared with the sham surgery group. Additionally, knockdown of KDM4A decreased BDNF expression and microgliosis and reduced neuropathic pain-like behaviors in BPA rats. Conversely, KDM4A overexpression increased BDNF expression and microgliosis and exacerbated neuropathic pain. BDNF inhibitors and activators also regulated the activation of spinal microglia and neuropathic pain. Importantly, we showed that KDM4A modulates BDNF expression by regulating the methylation of histone 3 lysine 9 and histone 3 lysine 36 in its promoter region. CONCLUSION: Current findings suggest that the upregulation of KDM4A increases BDNF expression in the spinal cord in rats after BPA, contributing to microgliosis, neuroinflammation, and neuropathic pain.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Guo J, Gao K, Chen X, et al. KDM4A facilitates neuropathic pain and microglial M1 polarization by regulating BDNF in a rat model of brachial plexus avulsion. Reg Anesth Pain Med. 2026. PMID: 39532465. doi:10.1136/rapm-2024-105801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。